CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | BLOCH KATHLEEN P. Interim CFO | Purchase | +1,100 | $2.85 | $3K | 44,800 |
| 2023-05-25 | BLOCH KATHLEEN P. Interim CFO | Purchase | +1,100 | $2.84 | $3K | 45,900 |
| 2023-05-25 | BLOCH KATHLEEN P. Interim CFO | Purchase | +1,100 | $2.85 | $3K | 47,000 |
| 2023-05-10 | BLOCH KATHLEEN P. Interim CFO | Purchase | +5,000 | $3.06 | $15K | 38,700 |
| 2023-05-10 | BLOCH KATHLEEN P. Interim CFO | Purchase | +2,000 | $3.13 | $6K | 40,700 |
| 2023-05-10 | BLOCH KATHLEEN P. Interim CFO | Purchase | +3,000 | $3.17 | $10K | 43,700 |
| 2023-04-04 | Capponi Vincent See Remarks | Option exercise | +10,000 | $2.88 | $29K | 511,989 |
| 2023-04-04 | Capponi Vincent See Remarks | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2023-04-03 | Chan Phillip P. Chief Executive Officer | Option exercise | +30,500 | $2.88 | $88K | 927,779 |
| 2023-04-03 | Chan Phillip P. Chief Executive Officer | Option exercise · Stock Option (right to buy) | −30,500 | 0 | ||
| 2023-02-27 | Sobel Alan D. Director | Gift | +2,000 | 81,300 | ||
| 2023-02-27 | Sobel Alan D. Director | Gift | −2,000 | 0 | ||
| 2023-02-06 | Kraus Al Director | Option exercise | +12,000 | $2.65 | $32K | 142,046 |
| 2023-02-06 | Kraus Al Director | Option exercise · Stock Option (right to buy) | −12,000 | 0 | ||
| 2022-12-08 | Chan Phillip P. Chief Executive Officer | Purchase | +5,859 | $1.26 | $7K | 897,279 |
| 2022-12-07 | Chan Phillip P. Chief Executive Officer | Purchase | +9,850 | $1.26 | $12K | 891,420 |
| 2022-12-06 | Chan Phillip P. Chief Executive Officer | Purchase | +14,291 | $1.26 | $18K | 881,570 |
| 2022-09-08 | Chan Phillip P. Chief Executive Officer | Purchase | +35,000 | $1.70 | $60K | 867,279 |
| 2022-08-25 | Kim Jiny Director | Purchase | +1,000 | $1.91 | $2K | 70,300 |
| 2022-08-10 | Sobel Alan D. Director | Grant or award · Stock Option (right to buy) | +18,975 | 18,975 |
Page 7 of 35 · 698 trades